RU2000125889A - SUBSTITUTED BISINDOLYMALEIMIDES INTENDED TO INHIBIT CELL PROLIFERATION - Google Patents
SUBSTITUTED BISINDOLYMALEIMIDES INTENDED TO INHIBIT CELL PROLIFERATIONInfo
- Publication number
- RU2000125889A RU2000125889A RU2000125889/04A RU2000125889A RU2000125889A RU 2000125889 A RU2000125889 A RU 2000125889A RU 2000125889/04 A RU2000125889/04 A RU 2000125889/04A RU 2000125889 A RU2000125889 A RU 2000125889A RU 2000125889 A RU2000125889 A RU 2000125889A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutically acceptable
- compound
- denotes
- formula
- intended
- Prior art date
Links
Claims (8)
где R1 обозначает водород и R2 обозначает метил, или R1 обозначает метил и R2 обозначает водород, или R1 обозначает гидроксиметил и R2 обозначает метил,
а также его фармацевтически приемлемые пролекарства или фармацевтически приемлемые соли.1. The compound of the formula
where R 1 denotes hydrogen and R 2 denotes methyl, or R 1 denotes methyl and R 2 denotes hydrogen, or R 1 denotes hydroxymethyl and R 2 denotes methyl,
as well as its pharmaceutically acceptable prodrugs or pharmaceutically acceptable salts.
и его фармацевтически приемлемые пролекарства или фармацевтически приемлемые соли этого соединения.2. The compound according to claim 1 of formula
and its pharmaceutically acceptable prodrugs or pharmaceutically acceptable salts of this compound.
и его фармацевтически приемлемые пролекарства или фармацевтически приемлемые соли этого соединения.3. The compound of the formula
and its pharmaceutically acceptable prodrugs or pharmaceutically acceptable salts of this compound.
и его фармацевтически приемлемые пролекарства или фармацевтически приемлемые соли этого соединения.4. The compound of the formula
and its pharmaceutically acceptable prodrugs or pharmaceutically acceptable salts of this compound.
где R1 обозначает водород и R2 обозначает метил, или R1 обозначает метил и R2 обозначает водород, или R1 обозначает гидроксиметил и R2 обозначает метил,
или его фармацевтически приемлемую соль или пролекарство этого соединения и фармацевтически приемлемый носитель.5. A pharmaceutical composition comprising a compound of formula
where R 1 denotes hydrogen and R 2 denotes methyl, or R 1 denotes methyl and R 2 denotes hydrogen, or R 1 denotes hydroxymethyl and R 2 denotes methyl,
or its pharmaceutically acceptable salt or prodrug of this compound and a pharmaceutically acceptable carrier.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7833198P | 1998-03-17 | 1998-03-17 | |
| US60/078,331 | 1998-03-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2000125889A true RU2000125889A (en) | 2002-09-27 |
| RU2208612C2 RU2208612C2 (en) | 2003-07-20 |
Family
ID=22143350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2000125889/04A RU2208612C2 (en) | 1998-03-17 | 1999-03-10 | Substituted bis-indolimaleimides designated for inhibition of cell proliferation |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US6048887A (en) |
| EP (1) | EP1064279B1 (en) |
| JP (2) | JP5026633B2 (en) |
| KR (1) | KR100659411B1 (en) |
| CN (1) | CN1127500C (en) |
| AR (1) | AR018162A1 (en) |
| AT (1) | ATE243693T1 (en) |
| AU (1) | AU755673B2 (en) |
| BR (1) | BR9908882A (en) |
| CA (1) | CA2322689C (en) |
| CO (1) | CO5070675A1 (en) |
| CZ (1) | CZ299068B6 (en) |
| DE (1) | DE69909068T2 (en) |
| DK (1) | DK1064279T3 (en) |
| ES (1) | ES2203111T3 (en) |
| HR (1) | HRP20000585B1 (en) |
| HU (1) | HU228831B1 (en) |
| ID (1) | ID26353A (en) |
| IL (1) | IL138247A (en) |
| MA (1) | MA26613A1 (en) |
| MY (1) | MY121046A (en) |
| NO (1) | NO320306B1 (en) |
| NZ (1) | NZ506476A (en) |
| PE (1) | PE20000340A1 (en) |
| PL (1) | PL195323B1 (en) |
| PT (1) | PT1064279E (en) |
| RS (1) | RS49965B (en) |
| RU (1) | RU2208612C2 (en) |
| SA (1) | SA99191295B1 (en) |
| TR (1) | TR200002580T2 (en) |
| TW (1) | TW539676B (en) |
| WO (1) | WO1999047518A1 (en) |
| ZA (1) | ZA992072B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE243693T1 (en) * | 1998-03-17 | 2003-07-15 | Hoffmann La Roche | SUBSTITUTED BISINDOLYLMALEIMIDE TO INHIBIT CELL PROLIFERATION |
| US6350786B1 (en) * | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| US6559164B1 (en) | 1999-10-12 | 2003-05-06 | Hoffmann-La Roche Inc. | Substituted pyrroles suitable for continuous infusion |
| TR200200987T2 (en) * | 1999-10-12 | 2002-09-23 | F.Hoffmann-La Roche Ag | Substituted pyrroles for cancer treatment |
| US6313143B1 (en) * | 1999-12-16 | 2001-11-06 | Hoffmann-La Roche Inc. | Substituted pyrroles |
| US6281356B1 (en) * | 1999-12-22 | 2001-08-28 | Hoffmann-La Roche Inc. | Substituted pyrroles |
| US6326501B1 (en) * | 2000-04-19 | 2001-12-04 | Hoffmann-La Roche Inc. | Methylation of indole compounds using dimethyl carbonate |
| US7129250B2 (en) * | 2000-05-19 | 2006-10-31 | Aegera Therapeutics Inc. | Neuroprotective and anti-proliferative compounds |
| CA2308994A1 (en) * | 2000-05-19 | 2001-11-19 | Aegera Therapeutics Inc. | Neuroprotective compounds |
| US6482847B2 (en) | 2000-10-03 | 2002-11-19 | Hoffmann-La Roche Inc. | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability |
| US6469179B1 (en) | 2000-10-03 | 2002-10-22 | Hoffmann-La Roche Inc. | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability |
| US6548531B2 (en) | 2001-02-09 | 2003-04-15 | Hoffmann-La Roche Inc. | Method for cancer therapy |
| WO2002102373A1 (en) * | 2001-06-15 | 2002-12-27 | F. Hoffmann-La Roche Ag | Method for administration of cancer therapeutic |
| US20030139373A1 (en) * | 2001-11-20 | 2003-07-24 | Breimer Lars Holger | Method for cancer therapy |
| WO2008117935A1 (en) * | 2007-03-28 | 2008-10-02 | Industry-Academic Cooperation Foundation, Yonsei University | Nk cell activating molecules, nk cells and pharmaceutical compositons comprising the same |
| CN102924437B (en) * | 2012-11-19 | 2014-07-02 | 东华大学 | 3-piperazine-4-indol maleimide compound and preparation and application thereof |
| WO2019000224A1 (en) * | 2017-06-27 | 2019-01-03 | 中国海洋大学 | Bisindolylmaleimide derivative and preparation method and use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ280738B6 (en) * | 1988-02-10 | 1996-04-17 | F. Hoffmann - La Roche And Co., Aktiengesellschaft | Substituted pyrroles, their use for preparing medicaments and medicaments based thereon |
| US5380746A (en) * | 1989-05-05 | 1995-01-10 | Goedecke Aktiengesellschaft | Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| AU1339895A (en) * | 1993-12-23 | 1995-07-10 | Eli Lilly And Company | Protein kinase c inhibitors |
| PE91598A1 (en) * | 1996-07-29 | 1998-12-24 | Hoffmann La Roche | SUBSTITUTED PYRROLES |
| PE91498A1 (en) * | 1996-07-29 | 1998-12-22 | Hoffmann La Roche | SUBSTITUTED PYRROLES |
| PE91698A1 (en) * | 1996-07-29 | 1998-12-24 | Hoffmann La Roche | SUBSTITUTED PYRROLES |
| ATE243693T1 (en) * | 1998-03-17 | 2003-07-15 | Hoffmann La Roche | SUBSTITUTED BISINDOLYLMALEIMIDE TO INHIBIT CELL PROLIFERATION |
-
1999
- 1999-03-10 AT AT99915558T patent/ATE243693T1/en active
- 1999-03-10 ID IDW20001730A patent/ID26353A/en unknown
- 1999-03-10 TR TR2000/02580T patent/TR200002580T2/en unknown
- 1999-03-10 NZ NZ506476A patent/NZ506476A/en not_active IP Right Cessation
- 1999-03-10 KR KR1020007010323A patent/KR100659411B1/en not_active Expired - Lifetime
- 1999-03-10 DK DK99915558T patent/DK1064279T3/en active
- 1999-03-10 WO PCT/EP1999/001534 patent/WO1999047518A1/en not_active Ceased
- 1999-03-10 CZ CZ20003384A patent/CZ299068B6/en not_active IP Right Cessation
- 1999-03-10 CA CA002322689A patent/CA2322689C/en not_active Expired - Lifetime
- 1999-03-10 DE DE69909068T patent/DE69909068T2/en not_active Expired - Lifetime
- 1999-03-10 PT PT99915558T patent/PT1064279E/en unknown
- 1999-03-10 AU AU34099/99A patent/AU755673B2/en not_active Expired
- 1999-03-10 HR HR20000585A patent/HRP20000585B1/en not_active IP Right Cessation
- 1999-03-10 HU HU0101258A patent/HU228831B1/en unknown
- 1999-03-10 JP JP2000536713A patent/JP5026633B2/en not_active Expired - Lifetime
- 1999-03-10 BR BR9908882-7A patent/BR9908882A/en not_active Application Discontinuation
- 1999-03-10 RU RU2000125889/04A patent/RU2208612C2/en active
- 1999-03-10 RS YUP-552/00A patent/RS49965B/en unknown
- 1999-03-10 IL IL13824799A patent/IL138247A/en not_active IP Right Cessation
- 1999-03-10 PL PL342964A patent/PL195323B1/en unknown
- 1999-03-10 ES ES99915558T patent/ES2203111T3/en not_active Expired - Lifetime
- 1999-03-10 CN CN99804045A patent/CN1127500C/en not_active Expired - Lifetime
- 1999-03-10 EP EP99915558A patent/EP1064279B1/en not_active Expired - Lifetime
- 1999-03-12 MA MA25492A patent/MA26613A1/en unknown
- 1999-03-12 PE PE1999000199A patent/PE20000340A1/en not_active IP Right Cessation
- 1999-03-15 CO CO99015752A patent/CO5070675A1/en unknown
- 1999-03-15 TW TW088103914A patent/TW539676B/en not_active IP Right Cessation
- 1999-03-15 MY MYPI99000952A patent/MY121046A/en unknown
- 1999-03-15 ZA ZA9902072A patent/ZA992072B/en unknown
- 1999-03-15 AR ARP990101117A patent/AR018162A1/en active IP Right Grant
- 1999-03-16 US US09/268,887 patent/US6048887A/en not_active Expired - Lifetime
- 1999-04-13 SA SA99191295A patent/SA99191295B1/en unknown
-
2000
- 2000-09-14 NO NO20004579A patent/NO320306B1/en not_active IP Right Cessation
-
2010
- 2010-06-02 JP JP2010126632A patent/JP2010222366A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2000125889A (en) | SUBSTITUTED BISINDOLYMALEIMIDES INTENDED TO INHIBIT CELL PROLIFERATION | |
| RU2221798C2 (en) | Imidazonaphthyridines, pharmaceutical composition based on thereof, method for stimulating biosynthesis of cytokine and intermediate compounds | |
| RU94040390A (en) | Derivatives of vinyleneazaindole, method of their synthesis, pharmaceutical composition | |
| CA2290918A1 (en) | Heteroaromatic bicyclic derivatives useful as anticancer agents | |
| CA2392973A1 (en) | Benzoimidazole derivatives useful as antiproliferative agents | |
| MX2010003868A (en) | Chiral cis-imidazolines. | |
| RU94030812A (en) | DERIVATIVES OF PHOSPHONOANATIC ACID, METHOD OF THEIR PRODUCTION AND CONTAINING THESE COMPOUNDS PHARMACEUTICAL COMPOSITIONS | |
| RU2008141850A (en) | LIQUID PHARMACEUTICAL PRODUCT WITH IMMEDIATE RELEASE | |
| TR200103395T2 (en) | 13-methyl erythromycin derivatives. | |
| KR890000470A (en) | 2,2-dimethylchroman-3-ol derivative, preparation method thereof, and pharmaceutical composition containing same | |
| RU2002123641A (en) | S-4 carbonate-containing taxanes | |
| RU2002100058A (en) | 1-Methylcarbapenem Crystal Derivatives | |
| RU2003134629A (en) | CEPHEMA COMPOUNDS | |
| EE200000472A (en) | Antineoplastic agents | |
| EP0992509A3 (en) | Novel macrolide derivatives | |
| AR029347A1 (en) | ADENINE COMPOUND, ISOGNANINE COMPOUND AND 2,6-DITIOXANTINE AS A PRECURSOR OF THE SAME, USE OF SUCH COMPOUNDS TO PREPARE A PHARMACEUTICAL COMPOSITION AND SUCH PHARMACEUTICAL COMPOSITION | |
| RU2002130247A (en) | OXADIAZOLE DERIVATIVES WITH ANTITUMER ACTION | |
| JP2002506864A5 (en) | ||
| RU94039545A (en) | New adenosine derivatives, methods of their synthesis, pharmaceutical compositions based on thereof, methods of preparing pharmaceutical compositions and their use | |
| SE0302570D0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| EP1109560A4 (en) | Compounds useful as aicarft inhibitors | |
| EA200101241A1 (en) | INDOLA DERIVATIVES | |
| RU2220965C2 (en) | Sulfonamide-substituted compounds and pharmaceutical composition based on thereof | |
| EA200700144A1 (en) | PYRIDOPYRIMIDINE DERIVATIVES, THEIR RECEIVING, THEIR APPLICATION IN THERAPY | |
| RU2004133388A (en) | NEW SALTS |